Wang N, Lin Q, Fan H, Wang Y, Shu C, Wang N
J Med Virol. 2024; 96(11):e70036.
PMID: 39529466
PMC: 11600477.
DOI: 10.1002/jmv.70036.
Zhang W, Wang X, Zhang H, Pan Y, Ma W, Xu Y
J Virol. 2024; 98(11):e0154223.
PMID: 39445829
PMC: 11575335.
DOI: 10.1128/jvi.01542-23.
Viceconte G, Buonomo A, DAgostino A, Foggia M, Di Fusco A, Pinchera B
J Fungi (Basel). 2023; 9(8).
PMID: 37623609
PMC: 10455879.
DOI: 10.3390/jof9080838.
Liana P, Samosir A, Sari N, Andriani R, Verdiansah V, Hidayatullah H
PeerJ. 2023; 11:e15509.
PMID: 37377785
PMC: 10292192.
DOI: 10.7717/peerj.15509.
Aharon A, Dangot A, Kinaani F, Zavaro M, Bannon L, Bar-Lev T
Int J Mol Sci. 2023; 24(6).
PMID: 36982991
PMC: 10054500.
DOI: 10.3390/ijms24065918.
pneumonia in COVID-19 patients: A comprehensive review.
Sasani E, Bahrami F, Salehi M, Aala F, Bakhtiari R, Abdollahi A
Heliyon. 2023; 9(2):e13618.
PMID: 36789388
PMC: 9911155.
DOI: 10.1016/j.heliyon.2023.e13618.
When the clock ticks wrong with COVID-19.
Papagerakis S, Said R, Ketabat F, Mahmood R, Pundir M, Lobanova L
Clin Transl Med. 2022; 12(11):e949.
PMID: 36394205
PMC: 9670202.
DOI: 10.1002/ctm2.949.
Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact.
Zhang S, Asquith B, Szydlo R, Tregoning J, Pollock K
Immunother Adv. 2022; 1(1):ltab015.
PMID: 35965490
PMC: 9364037.
DOI: 10.1093/immadv/ltab015.
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients.
Trujillo-Rodriguez M, Munoz-Muela E, Serna-Gallego A, Praena-Fernandez J, Perez-Gomez A, Gasca-Capote C
PLoS One. 2022; 17(7):e0269875.
PMID: 35834501
PMC: 9282584.
DOI: 10.1371/journal.pone.0269875.
The first detection of Pneumocystis jirovecii in asthmatic patients post-COVID-19 in Jordan.
Alsayed A, Talib W, Al-Dulaimi A, Daoud S, Al Maqbali M
Bosn J Basic Med Sci. 2022; 22(5):784-790.
PMID: 35603769
PMC: 9519162.
DOI: 10.17305/bjbms.2022.7335.
Correlation of the Imbalance in the Circulating Lymphocyte Subsets With C-Reactive Protein and Cardio-Metabolic Conditions in Patients With COVID-19.
Tyurin A, Salimgareeva M, Miniakhmetov I, Khusainova R, Samorodov A, Pavlov V
Front Immunol. 2022; 13:856883.
PMID: 35603207
PMC: 9120577.
DOI: 10.3389/fimmu.2022.856883.
A case report describing the immune response of an infant with congenital heart disease and severe COVID-19.
Wurzel D, Neeland M, Anderson J, Abo Y, Do L, Donato C
Commun Med (Lond). 2022; 1:47.
PMID: 35602234
PMC: 9053208.
DOI: 10.1038/s43856-021-00047-7.
Case series of the first three severe COVID-19 patients treated with the secretome of hypoxia-mesenchymal stem cells in Indonesia.
Putra A, Widyatmoko A, Ibrahim S, Amansyah F, Amansyah F, Berlian M
F1000Res. 2022; 10:228.
PMID: 35350705
PMC: 8927740.
DOI: 10.12688/f1000research.51191.2.
Vitamin D can reduce severity in COVID-19 through regulation of PD-L1.
Aygun H
Naunyn Schmiedebergs Arch Pharmacol. 2022; 395(4):487-494.
PMID: 35099571
PMC: 8802291.
DOI: 10.1007/s00210-022-02210-w.
Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience.
Gentile I, Viceconte G, Lanzardo A, Zotta I, Zappulo E, Pinchera B
Int J Environ Res Public Health. 2021; 18(21).
PMID: 34769913
PMC: 8582834.
DOI: 10.3390/ijerph182111399.
Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection.
Yamamoto A, Wada H, Ichikawa Y, Mizuno H, Tomida M, Masuda J
J Clin Med. 2021; 10(17).
PMID: 34501223
PMC: 8432011.
DOI: 10.3390/jcm10173775.
IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial.
Moll-Bernardes R, Silvestre de Sousa A, Macedo A, Lopes R, Vera N, Maia L
Front Cardiovasc Med. 2021; 8:702507.
PMID: 34386533
PMC: 8353079.
DOI: 10.3389/fcvm.2021.702507.
Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China.
Wang M, Fan Y, Chai Y, Cheng W, Wang K, Cao J
Front Cell Infect Microbiol. 2021; 11:667487.
PMID: 34123873
PMC: 8195246.
DOI: 10.3389/fcimb.2021.667487.
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits.
Banerjee A, Ganguly U, Saha S, Chakrabarti S, Saini R, Rawal R
Expert Rev Anti Infect Ther. 2021; 19(10):1245-1258.
PMID: 33739215
PMC: 8022339.
DOI: 10.1080/14787210.2021.1905519.
Maturation of T and B Lymphocytes in the Assessment of the Immune Status in COVID-19 Patients.
Kwiecien I, Rutkowska E, Klos K, Wiesik-Szewczyk E, Jahnz-Rozyk K, Rzepecki P
Cells. 2020; 9(12).
PMID: 33291439
PMC: 7762118.
DOI: 10.3390/cells9122615.